Clinical Trials in Tennessee

Showing 15401-15420 of 17,345 trials

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

NCT00006013

RATIONALE: SU5416 may stop the growth of multiple myeloma by stopping blood flow to the cancer cells. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who have refractory or relapsed multiple myeloma.

Multiple Myeloma and Plasma Cell Neoplasm

Fox Chase Cancer Center21 participantsStarted Jun 2000

Tampa, Florida, United States • Chicago, Illinois, United States • Philadelphia, Pennsylvania, United States +1 more locations

COMPLETEDNA29 miles

Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants

NCT00087360

RATIONALE: Evaluating the knowledge and attitudes of healthy participants toward a new diet and gene test for colorectal cancer risk may help doctors improve acceptance of colorectal cancer screening. PURPOSE: This clinical trial is studying the knowledge and attitudes of healthy participants toward genetic and environmental risk assessment for colorectal cancer.

Colorectal Cancer

Fox Chase Cancer CenterStarted Nov 2003

Bethesda, Maryland, United States • Philadelphia, Pennsylvania, United States • Philadelphia, Pennsylvania, United States +1 more locations

COMPLETEDPhase 329 miles

Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer

NCT00002568

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug or combining chemotherapy with surgery may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy consisting of paclitaxel and cisplatin with or without surgery in treating patients with stage III ovarian epithelial cancer.

Ovarian Cancer

Gynecologic Oncology Group470 participantsStarted Jun 1994

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +52 more locations

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants

Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer

Find Trials by Condition in Tennessee

Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Comparison of Aneuploidy Risk Evaluations

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)

Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus

Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma

Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination

NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme

Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis

Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors